Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

Objective: It remains controversial whether to extend the course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). We conducted a study to investigate the benefits and risks of applying DAPT for different durations after PCI in acute coronary syndromes (ACS) patient...

Full description

Bibliographic Details

Published in:	Global Heart
Main Authors:	Jialun Han, Yi Zhang, Xiujin Shi, Baidi Lin, Yunnan Zhang, Ru Zhang, Yifan Wang, Jialin Yan, Yang Lin
Format:	Article
Language:	English
Published:	Ubiquity Press 2023-03-01
Subjects:	acute coronary syndromes dual antiplatelet therapy percutaneous coronary intervention ticagrelor
Online Access:	https://globalheartjournal.com/articles/1185